endpts.com·Jul 2, 2026
Michel Dethue has been appointed as the new CEO of Danish neuro biotech Muna Therapeutics, succeeding Rita Balice-Gordon, while Genentech continues to experience losses with another key scientist departing.
The content does not provide any specific insights or actionable takeaways directly relevant to your interests in healthtech, biotech, or related fields. It primarily highlights personnel changes at Muna Therapeutics and Genentech, which may not be directly actionable unless you are tracking leadership movements in specific companies for strategic partnership or investment reasons.